Total planned funding: $124,516,040
Allocations
Countries/Regions
Ukraine | $124,516,040 |
Organizational Types
Private Contractor | $33,140,981 |
NGO | $27,721,854 |
Unknown | $23,849,720 |
Own Agency | $15,920,371 |
Multi-lateral Agency | $11,275,607 |
University | $5,410,000 |
Implementing Agency | $3,972,000 |
Other USG Agency | $3,225,507 |
Program Areas
Governance and Systems | $54,116,979 |
Treatment | $24,676,485 |
Prevention | $14,771,484 |
Management and Operations | $10,745,469 |
Testing | $10,602,687 |
Care | $9,190,236 |
Budget Codes
OHSS: Health Systems Strengthening | $27,578,263 |
HVSI: Strategic Information | $16,669,176 |
HTXS: Treatment: Adult Treatment | $13,271,195 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HVMS: Management and Operations | $10,745,469 |
HVCT: Testing: HIV Testing and Counseling | $10,602,687 |
HLAB: Laboratory Infrastructure | $9,869,540 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,475,105 |
HVTB: Care: TB/HIV | $6,305,330 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,229,456 |
HMBL: Biomedical Prevention: Blood Safety | $1,974,627 |
HBHC: Care: Adult Care and Support | $1,817,824 |
HKID: Care: Orphans and Vulnerable Children | $1,067,082 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $92,296 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
Top Partner Programs
Not Available:
$24,554,436
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$13,649,784
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions